Edward Hayter , Vijay Badial , Reece Barter , Harry Hodgson , Raymond E. Anakwe
{"title":"Predicting red blood cell transfusion for primary hip and knee arthroplasty: Designing a hub and spoke high-volume arthroplasty model","authors":"Edward Hayter , Vijay Badial , Reece Barter , Harry Hodgson , Raymond E. Anakwe","doi":"10.1016/j.jcot.2025.102974","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Waiting lists for elective surgery are at record levels. Consolidating elective care into superhubs where high-volume surgery can be undertaken efficiently is an attractive solution. These pathways should be safe but also efficient and convenient for patients.</div><div>We undertook this study to develop a model that would reliably predict healthy (American Society of Anaesthesiologists [ASA] class 1 and 2) patients who could be treated on a streamlined pathway and who would reliably not require red blood cell transfusion during their inpatient admission.</div></div><div><h3>Methods</h3><div>We retrospectively identified all patients undergoing primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) at our centre over a five-year period. We used binary logistic regression to develop a predictive model based on these variables.</div></div><div><h3>Results</h3><div>We identified 13-preoperative candidate variables from our literature search and used these to construct our predictive model. The final validated model was highly effective in predicting those patients who would not need a red blood cell transfusion (area under curve = 0.945).</div></div><div><h3>Conclusion</h3><div>Our model reliably predicts those healthy (ASA 1 or 2) patients undergoing primary THA or TKA surgery who will not require a red blood cell transfusion during their admission. These patients are suitable for this streamlined pathway without the need for unnecessary preoperative patient tests and travel.</div></div><div><h3>Level of evidence</h3><div>III.</div></div>","PeriodicalId":53594,"journal":{"name":"Journal of Clinical Orthopaedics and Trauma","volume":"64 ","pages":"Article 102974"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Orthopaedics and Trauma","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0976566225000700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Predicting red blood cell transfusion for primary hip and knee arthroplasty: Designing a hub and spoke high-volume arthroplasty model
Background
Waiting lists for elective surgery are at record levels. Consolidating elective care into superhubs where high-volume surgery can be undertaken efficiently is an attractive solution. These pathways should be safe but also efficient and convenient for patients.
We undertook this study to develop a model that would reliably predict healthy (American Society of Anaesthesiologists [ASA] class 1 and 2) patients who could be treated on a streamlined pathway and who would reliably not require red blood cell transfusion during their inpatient admission.
Methods
We retrospectively identified all patients undergoing primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) at our centre over a five-year period. We used binary logistic regression to develop a predictive model based on these variables.
Results
We identified 13-preoperative candidate variables from our literature search and used these to construct our predictive model. The final validated model was highly effective in predicting those patients who would not need a red blood cell transfusion (area under curve = 0.945).
Conclusion
Our model reliably predicts those healthy (ASA 1 or 2) patients undergoing primary THA or TKA surgery who will not require a red blood cell transfusion during their admission. These patients are suitable for this streamlined pathway without the need for unnecessary preoperative patient tests and travel.
期刊介绍:
Journal of Clinical Orthopaedics and Trauma (JCOT) aims to provide its readers with the latest clinical and basic research, and informed opinions that shape today''s orthopedic practice, thereby providing an opportunity to practice evidence-based medicine. With contributions from leading clinicians and researchers around the world, we aim to be the premier journal providing an international perspective advancing knowledge of the musculoskeletal system. JCOT publishes content of value to both general orthopedic practitioners and specialists on all aspects of musculoskeletal research, diagnoses, and treatment. We accept following types of articles: • Original articles focusing on current clinical issues. • Review articles with learning value for professionals as well as students. • Research articles providing the latest in basic biological or engineering research on musculoskeletal diseases. • Regular columns by experts discussing issues affecting the field of orthopedics. • "Symposia" devoted to a single topic offering the general reader an overview of a field, but providing the specialist current in-depth information. • Video of any orthopedic surgery which is innovative and adds to present concepts. • Articles emphasizing or demonstrating a new clinical sign in the art of patient examination is also considered for publication. Contributions from anywhere in the world are welcome and considered on their merits.